Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 44
Filtrar
1.
Methods Mol Biol ; 2418: 113-127, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35119663

RESUMO

Reverse transcription-quantitative RT-PCR (RT-qPCR) is a powerful tool for assessing gene transcription levels. The technique is especially useful for measuring estrogen receptor transcript levels as well as gene expression changes in response to estrogen stimulation as it is quick, accurate, and robust and allows the measurement of gene expression in a variety of tissues and cells. This chapter describes the protocols used for RNA extraction and analysis as well as for RT-qPCR assay using hydrolysis (TaqMan-type) probes.


Assuntos
Estrogênios , RNA , Estrogênios/farmacologia , RNA/genética , Reação em Cadeia da Polimerase em Tempo Real/métodos , Receptores de Estrogênio/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Transcrição Reversa
2.
Methods Mol Biol ; 1986: 17-33, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31115883

RESUMO

The DNA microarray is a powerful, flexible, nonbiased discovery technology. Microarrays can be used to assess processes from gene expression to long noncoding RNAs to specific pathologies, as well as many others. This chapter describes the protocol for DNA microarray analysis of differential gene expression using DNA sequences spotted on microscope slides.


Assuntos
Vidro/química , Análise de Sequência com Séries de Oligonucleotídeos/métodos , Animais , Células Cultivadas , Humanos , RNA/genética , RNA/isolamento & purificação , RNA Antissenso/genética
3.
Sci Rep ; 8(1): 13370, 2018 09 06.
Artigo em Inglês | MEDLINE | ID: mdl-30190587

RESUMO

Congenital hydrocephalus results from cerebrospinal fluid accumulation in the ventricles of the brain and causes severe neurological damage, but the underlying causes are not well understood. It is associated with several syndromes, including primary ciliary dyskinesia (PCD), which is caused by dysfunction of motile cilia. We previously demonstrated that mouse models of PCD lacking ciliary proteins CFAP221, CFAP54 and SPEF2 all have hydrocephalus with a strain-dependent severity. While morphological defects are more severe on the C57BL/6J (B6) background than 129S6/SvEvTac (129), cerebrospinal fluid flow is perturbed on both backgrounds, suggesting that abnormal cilia-driven flow is not the only factor underlying the hydrocephalus phenotype. Here, we performed a microarray analysis on brains from wild type and nm1054 mice lacking CFAP221 on the B6 and 129 backgrounds. Expression differences were observed for a number of genes that cluster into distinct groups based on expression pattern and biological function, many of them implicated in cellular and biochemical processes essential for proper brain development. These include genes known to be functionally relevant to congenital hydrocephalus, as well as formation and function of both motile and sensory cilia. Identification of these genes provides important clues to mechanisms underlying congenital hydrocephalus severity.


Assuntos
Encéfalo , Cílios , Regulação da Expressão Gênica , Hidrocefalia , Proteínas de Membrana , Animais , Encéfalo/metabolismo , Encéfalo/patologia , Cílios/genética , Cílios/metabolismo , Cílios/patologia , Modelos Animais de Doenças , Humanos , Hidrocefalia/genética , Hidrocefalia/metabolismo , Hidrocefalia/patologia , Proteínas de Membrana/biossíntese , Proteínas de Membrana/genética , Camundongos , Camundongos Knockout , Especificidade da Espécie
4.
Front Physiol ; 8: 594, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28861005

RESUMO

Background: The COP9 signalosome (CSN) consisting of 8 unique protein subunits (COPS1 through COPS8) serves as the cullin deneddylase, regulating the catalytic dynamics of cullin RING ligases (CRLs), the largest family of ubiquitin ligases Background: The COP9 signalosome (CSN) consisting of 8 unique protein subunits (COPS1 through COPS8) serves as the cullin deneddylase, regulating the catalytic dynamics of cullin RING ligases (CRLs), the largest family of ubiquitin ligases. Supported primarily by the decrease of substrate receptor (SR) proteins of CRLs in cells deficient of a CSN subunit, CSN-mediated cullin deneddylation is believed to prevent autoubiquitination and self-destruction of the SR in active CRLs. However, it is unclear whether the decrease in SRs is solely due to protein destabilization. Moreover, our prior studies have demonstrated that cardiac specific knockout of Cops8 (Cops8-CKO) impairs autophagosome maturation and causes massive necrosis in cardiomyocytes but the underlying mechanism remains poorly understood. Given that Cops8 is nucleus-enriched and a prior report showed its binding to the promoter of several genes and association of its ablation with decreased mRNA levels of these genes, we sought to determine the dynamic changes of myocardial transcriptome in mice with perinatal Cops8-CKO and to explore their functional implications. Methods and Results: Myocardial transcriptomes of Cops8flox/flox , Cops8flox/+::Myh6-Cre, and Cops8flox/flox::Myh6-Cre littermate mice at postnatal 2 and 3 weeks were analyzed. The data were imported into an in-house analysis pipeline using Bioconductor for quantile normalization and statistical analysis. Differentially expressed genes (DEGs) between groups at each time point or between time points within the group were revealed by t-test. Genes with p < 0.05 after Benjamini and Hochberg false discovery rate correction for multiple hypothesis testing were considered as significant DEGs. We found that (1) the Ingenuity Pathway Analysis (IPA) revealed significant enrichment of DEGs in multiple pathways, especially those responding to oxidative stress, in homozygous Cops8-CKO hearts at both 2 and 3 weeks, corroborating the occurrence of massive cardiomyocyte necrosis at 3 weeks; (2) the decreases in multiple CRL SR proteins were associated with decreased transcript levels; and (3) enrichment of DEGs in the chromatin remodeling pathway and the microtubule motility and vesicle trafficking pathways. Conclusions: Our data are consistent with the notion that Cops8/CSN plays a role in the transcriptional regulation of CRL SRs and in the redox and vesicle trafficking pathways.

5.
Mol Oncol ; 10(7): 1099-117, 2016 08.
Artigo em Inglês | MEDLINE | ID: mdl-27233943

RESUMO

The synthetic steroid mifepristone blocks the growth of ovarian cancer cells, yet the mechanism driving such effect is not entirely understood. Unbiased genomic and proteomic screenings using ovarian cancer cell lines of different genetic backgrounds and sensitivities to platinum led to the identification of two key genes upregulated by mifepristone and involved in the unfolded protein response (UPR): the master chaperone of the endoplasmic reticulum (ER), glucose regulated protein (GRP) of 78 kDa, and the CCAAT/enhancer binding protein homologous transcription factor (CHOP). GRP78 and CHOP were upregulated by mifepristone in ovarian cancer cells regardless of p53 status and platinum sensitivity. Further studies revealed that the three UPR-associated pathways, PERK, IRE1α, and ATF6, were activated by mifepristone. Also, the synthetic steroid acutely increased mRNA translation rate, which, if prevented, abrogated the splicing of XBP1 mRNA, a non-translatable readout of IRE1α activation. Moreover, mifepristone increased LC3-II levels due to increased autophagic flux. When the autophagic-lysosomal pathway was inhibited with chloroquine, mifepristone was lethal to the cells. Lastly, doses of proteasome inhibitors that are inadequate to block the activity of the proteasomes, caused cell death when combined with mifepristone; this phenotype was accompanied by accumulation of poly-ubiquitinated proteins denoting proteasome inhibition. The stimulation by mifepristone of ER stress and autophagic flux offers a therapeutic opportunity for utilizing this compound to sensitize ovarian cancer cells to proteasome or lysosome inhibitors.


Assuntos
Autofagia/efeitos dos fármacos , Lisossomos/metabolismo , Mifepristona/farmacologia , Neoplasias Ovarianas/genética , Neoplasias Ovarianas/patologia , Inibidores de Proteassoma/farmacologia , Biossíntese de Proteínas/efeitos dos fármacos , Resposta a Proteínas não Dobradas/efeitos dos fármacos , Fator 4 Ativador da Transcrição/metabolismo , Apoptose/efeitos dos fármacos , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Cloroquina/farmacologia , Cinamatos/farmacologia , Chaperona BiP do Retículo Endoplasmático , Fator de Iniciação 2 em Eucariotos/metabolismo , Feminino , Perfilação da Expressão Gênica , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Humanos , Lisossomos/efeitos dos fármacos , Platina/farmacologia , Biossíntese de Proteínas/genética , Puromicina/farmacologia , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Transdução de Sinais/efeitos dos fármacos , Tioureia/análogos & derivados , Tioureia/farmacologia , Tunicamicina/farmacologia
7.
Methods Mol Biol ; 1366: 1-10, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26585122

RESUMO

The estrogen receptors, ERα, ERß, and GPER, mediate the effects of estrogenic compounds on their target tissues. Estrogen receptors are located in the tissues of the female reproductive tract and breast as one would expect, but also in tissues as diverse as bone, brain, liver, colon, skin, and salivary gland. The purpose of this discussion of the estrogen receptors is to provide a brief overview of the estrogen receptors and estrogen action from perspectives such as the historical, physiological, pharmacological, pathological, structural, and ligand perspectives.


Assuntos
Receptor alfa de Estrogênio , Receptor beta de Estrogênio , Receptores de Estrogênio , Receptores Acoplados a Proteínas G , Animais , Suscetibilidade a Doenças , Antagonistas de Estrogênios/farmacologia , Receptor alfa de Estrogênio/efeitos dos fármacos , Receptor alfa de Estrogênio/genética , Receptor alfa de Estrogênio/metabolismo , Receptor beta de Estrogênio/efeitos dos fármacos , Receptor beta de Estrogênio/genética , Receptor beta de Estrogênio/metabolismo , Estrogênios/farmacologia , Evolução Molecular , Feminino , Humanos , Ligantes , Masculino , Receptores de Estrogênio/efeitos dos fármacos , Receptores de Estrogênio/genética , Receptores de Estrogênio/metabolismo , Receptores Acoplados a Proteínas G/efeitos dos fármacos , Receptores Acoplados a Proteínas G/genética , Receptores Acoplados a Proteínas G/metabolismo , Fatores de Risco , Fatores Sexuais , Transdução de Sinais
8.
Methods Mol Biol ; 1366: 19-28, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26585124

RESUMO

Real-time reverse transcription-polymerase chain reaction (RT-PCR), also known as quantitative RT-PCR (qRT-PCR), is a powerful tool for assessing gene transcription levels. The technique is especially useful for measuring estrogen receptor transcript levels as well as gene expression changes in response to estrogen stimulation as it is quick, accurate, robust, and allows the measurement of gene expression in a variety of tissues and cells. This chapter describes the protocols used for the real-time RT-PCR assay using hydrolysis (TaqMan-type) probes.


Assuntos
Estrogênios/farmacologia , Regulação da Expressão Gênica/efeitos dos fármacos , Reação em Cadeia da Polimerase em Tempo Real , Receptores de Estrogênio/efeitos dos fármacos , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Animais , Linhagem Celular , Sondas de DNA , Humanos , Hidrólise , RNA Mensageiro/metabolismo , Receptores de Estrogênio/genética , Receptores de Estrogênio/metabolismo , Taq Polimerase/metabolismo , Transcrição Gênica/efeitos dos fármacos , Fluxo de Trabalho
9.
Methods Mol Biol ; 1366: 115-129, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26585131

RESUMO

DNA microarray is a powerful, non-biased discovery technology that allows the analysis of the expression of thousands of genes at a time. The technology can be used for the identification of differential gene expression, genetic mutations associated with diseases, DNA methylation, single-nucleotide polymorphisms, and microRNA expression, to name a few. This chapter describes microarray technology for the analysis of differential gene expression in response to estrogen treatment.


Assuntos
Estrogênios/farmacologia , Etinilestradiol/farmacologia , Perfilação da Expressão Gênica/métodos , Regulação da Expressão Gênica/efeitos dos fármacos , Análise de Sequência com Séries de Oligonucleotídeos , Animais , Biologia Computacional , Bases de Dados Genéticas , Feminino , Ovariectomia , Reação em Cadeia da Polimerase , Ratos Sprague-Dawley , Fluxo de Trabalho
10.
Methods Mol Biol ; 1366: 533-548, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26585162

RESUMO

Estrogens are known to affect vascular function. In order to decipher the underlying mechanisms, it is essential to study the direct actions of estrogenic substances on blood vessels. There are two widely used approaches to assess the effects of estrogenic substances directly on blood vessels, the isolated perfused intact mesenteric vascular bed (McGregor preparation) and the isolated perfused/pressurized vessel approach. The McGregor preparation relies on constant flow with vascular reactivity assessed as changes in perfusion pressure. The isolated perfused/pressurized vessel approach uses a single vessel mounted on glass micropipettes. The main readout in this approach is vascular diameter. This chapter describes these approaches which remain cornerstones in the investigation of direct vascular actions of estrogenic substances.


Assuntos
Estrogênios/farmacologia , Técnicas In Vitro , Artérias Mesentéricas/efeitos dos fármacos , Moduladores Seletivos de Receptor Estrogênico/farmacologia , Animais , Pressão Arterial/efeitos dos fármacos , Feminino , Ovariectomia , Perfusão , Ratos Sprague-Dawley , Fatores de Tempo , Vasoconstrição/efeitos dos fármacos , Vasoconstritores/farmacologia , Vasodilatação/efeitos dos fármacos , Vasodilatadores/farmacologia , Fluxo de Trabalho
11.
J Patient Saf ; 11(4): 228-9, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24522211

RESUMO

Retained foreign bodies remain an area of potential patient harm. This case describes a retained needle from distant surgery discovered at the time of the needle count after myomectomy.


Assuntos
Corpos Estranhos/etiologia , Erros Médicos/estatística & dados numéricos , Adulto , Feminino , Corpos Estranhos/mortalidade , Cirurgia Geral , Humanos , Agulhas , Fatores de Risco , Instrumentos Cirúrgicos
12.
Menopause ; 21(2): 143-52, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-23760433

RESUMO

OBJECTIVE: This study aimed to assess the in vivo effects of estradiol treatment on arterial gene expression in atherosclerotic postmenopausal female monkeys. METHODS: Eight ovariectomized cynomolgus monkeys were fed atherogenic diets for 6.5 years. The left iliac artery was biopsied before randomization to the estradiol group (human equivalent dose of 1 mg/d, n = 4) or the vehicle group (n = 4) for 8 months. The right iliac artery was obtained at necropsy. Transcriptional profiles in pretreatment versus posttreatment iliac arteries were compared to assess the responses of atherosclerotic arteries to estradiol. RESULTS: Iliac artery plaque size did not differ between the estradiol group and the placebo group at baseline or during the treatment period. Nevertheless, estradiol treatment was associated with increased expression of 106 genes and decreased expression of 26 genes in the iliac arteries. Estradiol treatment increased the expression of extracellular matrix genes, including the α1 chain of type I collagen, the α2 chain of type VI collagen, and fibulin 2, suggestive of an increase in the proportion or phenotype of smooth muscles or fibroblasts in lesions. Also increased were components of the insulin-like growth factor pathway (insulin-like growth factor 1, insulin-like growth factor binding protein 4, and insulin-like growth factor binding protein 5) and the Wnt signaling pathway (secreted frizzled-related protein 2, secreted frizzled-related protein 4, low-density lipoprotein receptor-related protein 6, and Wnt1-inducible signaling pathway protein 2). CONCLUSIONS: Estradiol treatment of monkeys with established atherosclerosis affected iliac artery gene expression, suggesting changes in the cellular composition of lesions. Moreover, it is probable that the presence of atherosclerotic plaque affected the gene expression responses of arteries to estrogen.


Assuntos
Aterosclerose/metabolismo , Estradiol/farmacologia , Artéria Ilíaca/metabolismo , Ovariectomia , Pós-Menopausa , Transcriptoma/efeitos dos fármacos , Animais , Aterosclerose/etiologia , Aterosclerose/patologia , Dieta Aterogênica , Modelos Animais de Doenças , Estradiol/uso terapêutico , Proteínas da Matriz Extracelular/genética , Feminino , Humanos , Artéria Ilíaca/química , Artéria Ilíaca/patologia , Lipídeos/sangue , Macaca fascicularis , Análise de Sequência com Séries de Oligonucleotídeos , Somatomedinas/genética
13.
Clin Obstet Gynecol ; 55(3): 706-12, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22828102

RESUMO

Menopause is characterized by amenorrhea for 1 year due to the cessation of ovarian function. The hormonal treatment of menopause has significantly altered since the publication of initial results from the Women's Health Initiative continuous, combined, conjugated equine estrogen with medroxyprogesterone acetate study arm in 2002. Current studies suggest that treatment should be individualized and that the lowest dose of estrogen providing relief should be used for the shortest period of time in menopausal women who experience vasomotor symptoms or urogenital atrophy. Future studies into different delivery mechanisms such as transdermal applications and different agents, such as tibolone and raloxifene, will help refine the treatment of menopause.


Assuntos
Terapia de Reposição de Estrogênios/métodos , Estrogênios/uso terapêutico , Menopausa , Atrofia/tratamento farmacológico , Neoplasias da Mama/etiologia , Neoplasias do Endométrio/etiologia , Moduladores de Receptor Estrogênico/uso terapêutico , Terapia de Reposição de Estrogênios/efeitos adversos , Terapia de Reposição de Estrogênios/tendências , Feminino , Fogachos/tratamento farmacológico , Humanos , Pessoa de Meia-Idade , Norpregnenos/uso terapêutico , Seleção de Pacientes , Cloridrato de Raloxifeno/uso terapêutico , Vagina/patologia
14.
Physiol Behav ; 107(5): 670-9, 2012 Dec 05.
Artigo em Inglês | MEDLINE | ID: mdl-22450262

RESUMO

Social subjugation has widespread consequences affecting behavior and underlying neural systems. We hypothesized that individual differences in stress responsiveness were associated with differential expression of neurotrophin associated genes within the hippocampus and amygdala. To do this we examined the brains of hamsters placed in resident/intruder interactions, modified by the opportunity to escape from aggression. In the amygdala, aggressive social interaction stimulated increased BDNF receptor TrK(B) mRNA levels regardless of the ability to escape the aggressor. In contrast, the availability of escape limited the elevation of GluR(1) AMPA subunit mRNA. In the hippocampal CA(1), the glucocorticoid stress hormone, cortisol, was negatively correlated with BDNF and TrK(B) gene expression, but showed a positive correlation with BDNF expression in the DG. Latency to escape the aggressor was also negatively correlated with CA(1) BDNF expression. In contrast, the relationship between amygdalar TrK(B) and GluR(1) was positive with respect to escape latency. These results suggest that an interplay of stress and neurotrophic systems influences learned escape behavior. Animals which escape faster seem to have a more robust neurotrophic profile in the hippocampus, with the opposite of this pattern in the amygdala. We propose that changes in the equilibrium of hippocampal and amygdalar learning result in differing behavioral stress coping choices.


Assuntos
Agressão/fisiologia , Tonsila do Cerebelo/metabolismo , Reação de Fuga/fisiologia , Hipocampo/metabolismo , Plasticidade Neuronal/fisiologia , Tonsila do Cerebelo/fisiologia , Animais , Fator Neurotrófico Derivado do Encéfalo/metabolismo , Cricetinae , Regulação da Expressão Gênica/fisiologia , Hipocampo/fisiologia , Hidrocortisona/sangue , Masculino , Mesocricetus , Reação em Cadeia da Polimerase , Estresse Psicológico/metabolismo , Estresse Psicológico/fisiopatologia
15.
Fertil Steril ; 97(4): 948-9, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22325678

RESUMO

OBJECTIVE: To describe the association of müllerian agenesis with hypohidrotic ectodermal dysplasia. DESIGN: Case report. SETTING: University medical center. PATIENT(S): A 17-year-old woman with hypohidrotic ectodermal dysplasia referred for evaluation of primary amenorrhea. INTERVENTION(S): History, physical examination, and ultrasound. MAIN OUTCOME MEASURE(S): Physical findings of these two syndromes. RESULT(S): Physical examination and ultrasound demonstrated müllerian agenesis with findings of hypohidrotic ectodermal dysplasia. CONCLUSION(S): This is the first description of the association of müllerian agenesis with ectodermal dysplasia. This rare case might provide further insight into the development of the uterus and the ectoderm as well as its derivatives.


Assuntos
Displasia Ectodérmica/diagnóstico , Hipo-Hidrose/diagnóstico , Ductos Paramesonéfricos/anormalidades , Adolescente , Amenorreia/etiologia , Displasia Ectodérmica/complicações , Feminino , Humanos , Hipo-Hidrose/complicações , Hipo-Hidrose/congênito , Ductos Paramesonéfricos/diagnóstico por imagem , Exame Físico , Ultrassonografia
16.
Mol Cell Biochem ; 362(1-2): 103-14, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22038629

RESUMO

Hypertension is sexually dimorphic and modified by removal of endogenous sex steroids. This study tested the hypothesis that endogenous gonadal hormones exert differential effects on protein expression in the kidney and mesentery of SHR. At ~5 weeks of age male and female SHR underwent sham operation, orchidectomy, or ovariectomy (OVX). At 20-23 weeks of age, mean arterial pressure (MAP) was measured in conscious rats. The mesenteric arterial tree and kidneys were collected, processed for Western blots, and probed for Cu Zn superoxide dismutase (SOD1), soluble epoxide hydrolase (sEH), and Alpha 2A adrenergic receptor (A2AR) expression. MAP was unaffected by ovariectomy (Sham 164 ± 4: Ovariecttomy 159 ± 3 mm Hg). MAP was reduced by orchidectomy (Sham 189 ± 5:Orchidectomy 167 ± 2 mm Hg). In mesenteric artery, SOD1 expression was greater in male versus female SHR. Orchidectomy increased while ovariectomy decreased SOD1 expression. The kidney exhibited a different pattern of response. SOD1 expression was reduced in male compared to female SHR but gonadectomy had no effect. sEH expression was not significantly different among the groups in mesenteric artery. In kidney, sEH expression was greater in males compared to females. Ovariectomy but not orchidectomy increased sEH expression. A2AR expression was greater in female than male SHR in mesentery artery and kidney. Gonadectomy had no effect in either tissue. We conclude that sexually dimorphic hypertension is associated with regionally specific changes in expression of three key proteins involved in blood pressure control. These data suggest that broad spectrum inhibition or stimulation of these systems may not be the best approach for hypertension treatment. Instead regionally targeted manipulation of these systems should be investigated.


Assuntos
Pressão Sanguínea/fisiologia , Hormônios Gonadais/metabolismo , Hipertensão/fisiopatologia , Animais , Epóxido Hidrolases/biossíntese , Feminino , Humanos , Hipertensão/genética , Hipertensão/metabolismo , Rim/metabolismo , Masculino , Artérias Mesentéricas/metabolismo , Orquiectomia , Ovariectomia , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Ratos , Ratos Endogâmicos SHR , Ratos Sprague-Dawley , Receptores Adrenérgicos alfa 2/biossíntese , Caracteres Sexuais , Superóxido Dismutase/biossíntese , Superóxido Dismutase-1
17.
S D Med ; Spec No: 18-21, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21717812

RESUMO

A complex network of hormones from the pancreas, adipose tissue, stomach, intestines and the central nervous system coordinates regulation of metabolism and energy balance. Obesity disrupts this regulatory network. This paper reviews the anorexigenic and orexigenic hormones and their dysfunctional regulation in obesity.


Assuntos
Hormônios/fisiologia , Obesidade/fisiopatologia , Tecido Adiposo/fisiologia , Glucagon/fisiologia , Humanos , Insulina/fisiologia , Obesidade/metabolismo
18.
Menopause ; 18(10): 1087-95, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-21646924

RESUMO

OBJECTIVE: The aim of this study was to evaluate global gene expression patterns in the common iliac arteries of monkeys with a varied extent of atherosclerosis. METHODS: The left common iliac artery was removed from ovariectomized cynomolgus monkeys (n = 12) after 6.5 years of consuming a diet containing fat and cholesterol at levels comparable with those consumed in Western populations. Arterial gene expression was analyzed using DNA microarray and real-time reverse transcription-polymerase chain reaction. RESULTS: Significant differential expression of 986 genes was observed in iliac arteries containing moderate to large atherosclerotic plaques compared with normal/minimally affected reference group arteries. Atherosclerosis-associated genes included cytokines, chemokines, components of signal transduction pathways, and transcriptional activators and repressors, as well as other functional categories. Real-time reverse transcription-polymerase chain reaction confirmed a differential expression of genes chosen from a variety of functional categories. Specifically, the expression of genes for estrogen receptor-1, claudin 11, and brain heart protocadherin 7 was reduced, whereas the expression of genes for apolipoprotein E, growth differentiation factor 15, superoxide dismutase-2, SET domain bifurcated 2, phospholipase A2 group IIA, phospholipase A2 group VII, and ring finger protein 149 was increased in atherosclerotic arteries. CONCLUSIONS: The gene expression environment in arteries containing atherosclerotic plaques is profoundly different from that of relatively unaffected arteries and reflects the cellular and molecular complexity of atherosclerosis and associated arterial remodeling processes.


Assuntos
Aterosclerose/genética , Perfilação da Expressão Gênica , Artéria Ilíaca/metabolismo , Animais , Apolipoproteínas E/biossíntese , Apolipoproteínas E/genética , Aterosclerose/fisiopatologia , Caderinas/biossíntese , Caderinas/genética , Claudinas/biossíntese , Claudinas/genética , Gorduras na Dieta/efeitos adversos , Modelos Animais de Doenças , Receptor alfa de Estrogênio/biossíntese , Receptor alfa de Estrogênio/genética , Feminino , Fator 15 de Diferenciação de Crescimento/biossíntese , Fator 15 de Diferenciação de Crescimento/genética , Histona-Lisina N-Metiltransferase/biossíntese , Histona-Lisina N-Metiltransferase/genética , Artéria Ilíaca/fisiopatologia , Macaca fascicularis , Ovariectomia , Fosfolipases A2/biossíntese , Fosfolipases A2/genética , Superóxido Dismutase/biossíntese , Superóxido Dismutase/genética
19.
Vascul Pharmacol ; 55(1-3): 42-9, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21658471

RESUMO

Estrogen has both beneficial and detrimental effects on the cardiovascular system. Selective estrogen receptor modulators (SERMs) exhibit partial estrogen agonist/antagonist activity in estrogen target tissues. Gene targets of estrogen and SERMs in the vasculature are not well-known. Thus, the present study tested the hypothesis that estrogens (ethinyl estradiol, estradiol benzoate, and equilin) and SERMs (tamoxifen and raloxifene) cause differential gene and protein expression in the vasculature. DNA microarray and real-time RT-PCR were used to investigate gene expression in the mesenteric arteries of estrogen and SERM treated ovariectomized rats. The genes shown to be differentially expressed included stearoyl-CoA desaturase (SCD), soluble epoxide hydrolase (sEH), secreted frizzled related protein-4 (SFRP-4), insulin-like growth factor-1 (IGF-1), phospholipase A2 group 1B (PLA2-G1B), and fatty acid synthase (FAS). Western blot further confirmed the differential expression of sEH, SFRP-4, FAS, and SCD protein. These results reveal that estrogens and SERMs cause differential gene and protein expression in the mesenteric artery. Consequently, the use of these agents may be associated with a unique profile of functional and structural changes in the mesenteric arterial circulation.


Assuntos
Estrogênios/metabolismo , Regulação da Expressão Gênica/efeitos dos fármacos , Artérias Mesentéricas/fisiologia , Receptores de Estrogênio/metabolismo , Moduladores Seletivos de Receptor Estrogênico/farmacologia , Animais , Feminino , Perfilação da Expressão Gênica , Regulação da Expressão Gênica/fisiologia , Artérias Mesentéricas/efeitos dos fármacos , Análise de Sequência com Séries de Oligonucleotídeos/métodos , Biossíntese de Proteínas , Cloridrato de Raloxifeno/farmacologia , Ratos , Ratos Sprague-Dawley , Reação em Cadeia da Polimerase em Tempo Real/métodos , Tamoxifeno/farmacologia
20.
Fertil Steril ; 95(7): 2434.e7-9, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21529797

RESUMO

OBJECTIVE: To describe atypical vasomotor symptoms that were secondary to primary hyperparathyroidism. DESIGN: Case report. SETTING: University medical center. PATIENT(S): A 57-year-old, postmenopausal woman with recalcitrant hot flushes. INTERVENTION(S): Parathyroid adenomectomy. MAIN OUTCOME MEASURE(S): Vasomotor symptom relief. RESULT(S): Postoperative relief of atypical vasomotor symptoms. CONCLUSION(S): A patient 17 years postmenopause presented with atypical vasomotor symptoms that did not respond to hormone therapy and proved to be due to hypercalcemia secondary to primary hyperparathyroidism. An atypical manifestation of a common condition or an uncharacteristic therapeutic response should alert health care providers to the possibility of a different diagnosis.


Assuntos
Adenoma/complicações , Fogachos/etiologia , Hipercalcemia/etiologia , Hipertireoidismo/etiologia , Neoplasias das Paratireoides/complicações , Adenoma/diagnóstico , Adenoma/cirurgia , Diagnóstico Diferencial , Feminino , Fogachos/diagnóstico , Humanos , Hipercalcemia/diagnóstico , Hipertireoidismo/diagnóstico , Hipertireoidismo/cirurgia , Neoplasias das Paratireoides/diagnóstico , Neoplasias das Paratireoides/cirurgia , Paratireoidectomia , Pós-Menopausa , Gravidez , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA